Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.46 USD | -0.67% |
|
-2.62% | -49.60% |
05-21 | Palisade Bio, Inc. Announces Presentation of Positive Preclinical Data from PALI-2108 | CI |
05-13 | Palisade Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-49.60% | 4.18M | |
+48.54% | 56.61B | |
+37.66% | 39.25B | |
-6.02% | 39.62B | |
-6.90% | 28.28B | |
+12.97% | 26.44B | |
-16.91% | 20.12B | |
+31.71% | 12.48B | |
+28.18% | 12.51B | |
+0.38% | 12.2B |
- Stock Market
- Equities
- SNCA Stock
- News Palisade Bio, Inc.
- Transcript : Seneca Biopharma, Inc. - Shareholder/Analyst Call